Storage is formulation-specific. Start with the exact product instructions, not a rule that every dry vial belongs in a freezer and every mixed vial in a fridge. Powder versus solution alone does not determine the answer.

A counterexample makes the limit clear. The March 2025 FDA label for EGRIFTA WR, a tesamorelin formulation, specifies room-temperature storage for its powder and says not to refrigerate or freeze it after mixing. These are product-specific instructions, not a protocol for other tesamorelin or research vials. Read the FDA label.

Correction, October 20, 2026: The earlier freezer/fridge chart and shelf-life statements were too broad. This update prioritizes exact formulation instructions and narrows the insulin experiment to its actual laboratory endpoint. Full clinical and source review remains pending.

The checklist: identify the exact formulation first

  • Sealed lyophilised vial: check its specified storage conditions. Dry powder is not automatically a freezer product.
  • Short-term storage: a generic promise of months in a fridge is not a validated shelf life for an unidentified formulation.
  • Transit or a temperature excursion: obtain product-specific advice rather than treating shipping without dry ice as proof of stability.
  • Reconstituted vial: use its own storage instructions and use-by limit. Mixing alone does not establish a refrigeration requirement.
  • Long-term storage: do not invent an extension by changing the temperature.
  • Packaging: retain the labelled storage information and any specified light protection.

Why powder versus solution is not the whole answer

The labelled formulation matters. The EGRIFTA WR example above contradicts the earlier universal dry-freezer, wet-fridge chart.

Identify the exact product and formulation

Record what the vial contains and which instructions apply. A compound name alone is not enough to transfer a storage rule.

Check the specified storage conditions

Do not substitute a generic freezer rule for the instructions on the product.

Check what changes after mixing

Consult the product-specific instructions for storage and the applicable use-by limit after mixing.

Check packaging and light protection

Keep the storage information with the vial. Follow the specified packaging and light-protection instructions.

Check whether freezing is permitted

Do not assume that freezing preserves a product, or that one cycle has an identical effect on every formulation. The cited laboratory mechanisms are not a universal storage specification.

Keep a usable storage history

An unidentified product or an unclear storage history cannot be resolved by a generic temperature chart.

How long each state lasts

There is no general shelf life established here for an arbitrary research-peptide vial. Product-specific stability evidence and instructions are required.

  • Frozen powder: no universal duration is established here.
  • Refrigerated powder: no universal duration is established here.
  • Reconstituted solution: no universal use-by period is established here.

The cited six-month experiment concerned twelve preserved insulin vials in a veterinary-journal laboratory study, not arbitrary research-peptide solutions. One of 454 cultures showed non-repeatable growth; sustained contamination was not identified under the study definition.[1]

6 months laboratory observation period for preserved insulin vials, not a general use-by limit PMID 37559404

That result concerns microbial sampling, not a validated six-month potency or use-by limit for other products. It does not replace their instructions.

What goes wrong, and what it costs you

  • Assuming that a protein experiment establishes the same freezing outcome for every peptide formulation.
  • Using a fridge or freezer without first checking whether the product belongs there.
  • Ignoring specified packaging or light-protection instructions.
  • Assuming that another freeze-thaw cycle renews the use-by period.
  • Diluting to a very low concentration for storage. More of the peptide ends up stuck to the container.
  • Losing the product identity, label or storage history.
Ice crystals growing around a shrinking pocket of concentrated solution

Freezing does not hold a solution still. It concentrates what is left between the crystals.

The chemistry behind each rule

Why dry beats wet. Water content governs the kinetics of degradation. It was established in solid-state work on human insulin, where the dry material was far more stable than the same peptide in solution.[2] Pharmaceutical freeze-drying is built on that principle: remove water to stabilise a molecule that will not survive storage wet.[3] Dry is not inert, though. Proteins and peptides run their own set of degradation reactions in the solid state, only more slowly.[4]

Why cold beats warm. A 2025 study measured solution-state degradation of semaglutide against pH, buffer, molarity and temperature, and all four moved the result.[5] Temperature is the variable you control at home.

What is degrading. Two routes dominate. Deamidation was pinned down decades ago in growth hormone releasing factor analogues in neutral aqueous solution.[6] Oxidation is the other: selective oxidation of methionine and tryptophan residues has been characterised in a therapeutic protein.[7] Neither leaves a visible sign.

Why light matters. Photo-degradation of therapeutic proteins has its own literature and its own mechanisms.[8] A carton solves it.

Why freezing a solution is the damaging one. Freezing-induced protein aggregation is driven in part by a pH shift as the solution concentrates during ice formation.[9] The peptide is not sitting still while frozen, it is being pushed into an increasingly concentrated, pH-shifted pocket between growing ice crystals. Freeze-thaw work in food proteins shows the same pattern: pH change during the cycle drives denaturation.[10]

Aggregates are worth avoiding for a specific reason. In licensed protein products they are the quality attribute regulators watch most closely, because aggregate content is linked to immunogenicity risk.[11]

Why very dilute solutions lose more. Cationic peptides adsorb measurably to glass and plastic surfaces.[12] At low concentration the container claims a larger share of what is in the vial.

What storage cannot fix

Two limits worth stating plainly:

  • Shelf life is compound-specific. Deamidation rate depends on sequence, so a figure quoted for one peptide carries no information about another. Any chart giving one shelf life for all peptides is guessing.
  • Storage assumes the vial held what the label said. For research-use material nothing independently establishes the mass or the purity, and no freezer compensates for that.

Use the exact formulation and its instructions. The chemistry below explains potential degradation mechanisms; it does not validate a universal storage temperature or shelf life.


This article is for research and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The peptides discussed here are sold for research use only and are not for human consumption. Nothing in this article constitutes medical advice. Consult a qualified clinician before making changes to a health, training, or supplementation protocol.

References

  1. Refrigerated multi-dose insulin vials remain sterile through 6 months of use.. The Journal of small animal practice, 2023.
  2. Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.. Pharmaceutical research, 1996.
  3. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.. Advances in experimental medicine and biology, 2018.
  4. Solid-state chemical stability of proteins and peptides.. Journal of pharmaceutical sciences, 1999.
  5. Effect of pH, buffers, molarity, and temperature on solution state degradation of semaglutide using LC-HRMS: A preformulation protocol for peptide drug delivery.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2025.
  6. Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Replacement of asparagine residues by serine stabilizes.. International journal of peptide and protein research, 1991.
  7. Selective Oxidation of Methionine and Tryptophan Residues in a Therapeutic IgG1 Molecule.. Journal of pharmaceutical sciences, 2015.
  8. Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects.. Pharmaceutical research, 2020.
  9. Freezing-induced protein aggregation - Role of pH shift and potential mitigation strategies.. Journal of controlled release : official journal of the Controlled Release Society, 2020.
  10. Effect of cellobiose on the myofibrillar protein denaturation induced by pH changes during freeze-thaw cycles.. Food chemistry, 2022.
  11. Protein aggregation and immunogenicity of biotherapeutics.. International journal of pharmaceutics, 2020.
  12. Adsorption of cationic peptides to solid surfaces of glass and plastic.. PloS one, 2015.